Merit Medical SystemsMMSI +2.77%79 Receivables Turnover is 1.86 as of Mar. 2026. GuruFocus rates MMSI with a GF Score™ of 79/100 and a GF Value™ of $97.03 (Modestly Undervalued). Among 811 Medical Devices & Instruments companies, Merit Medical Systems ranks better than 73.74% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Merit Medical Systems's Revenue for the
three
months ended in Mar. 2026 was $382 Mil. Merit Medical Systems's average Accounts Receivable for the
three
months ended in Mar. 2026 was $205 Mil.
Hence, Merit Medical Systems's Receivables Turnover for the
three
months ended in Mar. 2026 was 1.86.
Merit Medical Systems (NAS:MMSI) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Merit Medical Systems Receivables Turnover Related Terms
Merit Medical Systems Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Merit Medical Systems's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MMSI vs NVST, MMED, ICUI: Receivables Turnover Comparison
For the Medical Instruments & Supplies subindustry, Merit Medical Systems's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Merit Medical Systems Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Merit Medical Systems's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Merit Medical Systems's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Merit Medical Systems (MMSI) has a Receivables Turnover of 1.86 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Merit Medical Systems and its competitors. According to the industry distribution chart, Merit Medical Systems ranks #213 out of 811 companies in the Medical Devices & Instruments industry, placing it in the top 26.3%.
Is Merit Medical Systems' Receivables Turnover too high?
Merit Medical Systems' current Receivables Turnover is 1.86. The Medical Devices & Instruments industry median Receivables Turnover is 5.51. Merit Medical Systems' value of 1.86 is 66.2% below this industry median. Based on the distribution chart, Merit Medical Systems ranks #213 out of 811 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Merit Medical Systems has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Merit Medical Systems' Receivables Turnover compare to NVST and MMED?
According to the Medical Devices & Instruments industry distribution chart, Merit Medical Systems ranks #213 out of 811 companies for Receivables Turnover. This puts Merit Medical Systems in the upper half of its industry. The industry median Receivables Turnover is 5.51. Merit Medical Systems' value of 1.86 is 66.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.51, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Merit Medical Systems's current Receivables Turnover of 1.86 is 66.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Merit Medical Systems and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Merit Medical Systems's current Receivables Turnover is 1.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Merit Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Merit Medical Systems (MMSI) is currently considered Modestly Undervalued. The stock's GF Value™ is $97.03, compared to a current price of $73.44 — trading 24.3% below its estimated fair value. The current Receivables Turnover is 1.86 and 66.2% below the Medical Devices & Instruments industry median of 5.51. Merit Medical Systems' overall GF Score™ is 79/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Merit Medical Systems (MMSI), the current Receivables Turnover is 1.86 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Merit Medical Systems (MMSI) Overvalued in 2026?
Based on GuruFocus' analysis, Merit Medical Systems stock appears to be undervalued.
The current stock price of $73.44 is trading 24.3% below its estimated GF Value™ of $97.03.
GuruFocus considers Merit Medical Systems to be Modestly Undervalued.
Key valuation signals for MMSI:
Receivables Turnover: 1.86
GF Value™: $97.03 vs. price of $73.44 (24.3% below fair value)
Industry Position: 66.2% below the Medical Devices & Instruments median (#213 of 811)
No single metric tells the full story. See the MMSI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
79GF Score
Get the complete analysis for MMSI
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MMSI has been successfully added to your 
